Want to see WGS full AI Analyst Report?

GeneDx Holdings (WGS) Price & Analysis

975 Followers

WGS Stock Chart & Stats

$65.96

-$4.29(-4.42%)

At close: Jan 08 4:00 PM EST

$65.96

-$4.29(-4.42%)

Day’s Range― - ―

52-Week Range$32.21 - $170.87

Previous CloseN/A

Volume338.68K

Average Volume (3M)913.41K

Market Cap

$1.88B

Enterprise Value$1.88K

Total Cash (Recent Filing)$170.69M

Total Debt (Recent Filing)$168.19M

Price to Earnings (P/E)―

Beta0.98

Next Earnings

Aug 03, 2026

EPS Estimate

-0.19

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.66

Shares Outstanding29,688,026

10 Day Avg. Volume677,006

30 Day Avg. Volume913,407

Financial Highlights & Ratios

PEG Ratio2.86

Price to Book (P/B)11.35

Price to Sales (P/S)8.18

P/FCF Ratio245.23

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price Target

$80.29

Price Target Upside21.72% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

EPS Forecast (FY)-0.06

Revenue Forecast (FY)$478.37M

Bulls Say, Bears Say

Bulls Say

Gross Margin And Unit EconomicsSustained high adjusted gross margins (~69% Q1, ~70% target for 2026) indicate strong per-test unit economics for sequencing-based services. Durable margin strength supports a scalable business model as volume grows, underpinning management’s path to adjusted profitability and long-term operating leverage.

Proprietary Genomic Data AssetA large, proprietary dataset (>1M exomes/genomes and >8M phenotypic profiles) is a durable competitive moat: it improves diagnostic interpretation, enables differentiated clinical validation, strengthens payer discussions, and supports biopharma partnerships that compound value over multiple years.

Experienced Commercial Leadership HireHiring a senior diagnostics executive with ~30 years’ experience to lead commercial and lab operations is a structural improvement in management quality. It signals a focus on execution, revenue cycle and scaling sales coverage—durable drivers for growing test adoption and improving collections over time.

Bears Say

Negative Cash GenerationReversion to negative operating and free cash flow after positive 2025 levels weakens internal funding for growth and reduces financial flexibility. Persistent cash outflows raise the likelihood of external financing or cutbacks, constraining durable investment in commercial scale-up and product development.

Reimbursement And Mix PressureMaterial guidance cut and below‑plan blended ARR reflect structural reimbursement and product‑mix risks. Genome reimbursement remains immature and ARR improvement needs multiple quarters of payer coverage expansion, meaning sustainable revenue per test is uncertain for the near to medium term.

Non-core Underperformance And ImpairmentA sizeable impairment from non-core lines signals prior investment missteps and diverts capital and management attention. This reduces book value and highlights execution risk in ancillary offerings, potentially forcing resource reallocation away from core growth initiatives for an extended period.

GeneDx Holdings News

GeneDx price target raised to $85 from $55 at TD Cowen

TD Cowen raised the firm’s price target on GeneDx (WGS) to $85 from $55 and keeps a Buy...

5d ago

WGS

Shareholders Sue GeneDX as ‘Unprecedented’ Fabric Acquisition Racks up $31M Loss

A class action lawsuit has been filed against genomics company GeneDX. The action relates to claims over its acquisition...

10d ago

WGS

GeneDx price target raised to $74 from $70 at Guggenheim

Guggenheim raised the firm’s price target on GeneDx (WGS) to $74 from $70 and keeps a Buy rating...

21d ago

WGS

GeneDx price target raised to $63 from $50 at Piper Sandler

Piper Sandler analyst David Westenberg raised the firm’s price target on GeneDx (WGS) to $63 from $50 and...

27d ago

WGS

GeneDx Shareholders Back Director, Auditor and Pay Plans

GeneDx Holdings ( ($WGS) ) has issued an update. GeneDx Holdings held its Annual Meeting of Stockholders on...

27d ago

WGS

GeneDx Appoints Mark Gardner as New Company President

GeneDx Holdings ( ($WGS) ) has shared an update. On June 16, 2026, GeneDx Holdings announced it had...

1M ago

WGS

GeneDx appoints Gardner as President

GeneDx (WGS) announced the appointment of Mark Gardner as President, effective June 15, 2026. Reporting to Katherine Stueland,...

1M ago

WGS

GeneDx Holdings Corp. Faces Federal Securities Lawsuit After 49% Stock Plunge Tied to Fabric Acquisition Allegations

GeneDx Holdings Corp. (NASDAQ: WGS) is facing a federal securities lawsuit alleging that the company and its top executives...

1M ago

WGS

Insiders Are Buying These 3 Stocks, 5/18/26 — Should You Follow?

Insider buying often attracts attention because company executives typically understand their business better than most investors. When insiders...

2M ago

TXO

Midday Fly By: Palantir reports ‘beat and raise,’ Coinbase to cut staff

The major averages were broadly higher near noon as oil pulls back, though the ceasefire between the U.S....

3M ago

BRC

GeneDx price target lowered to $85 from $153 at Craig-Hallum

Craig-Hallum analyst Bill Bonello lowered the firm’s price target on GeneDx (WGS) to $85 from $153 and keeps...

3M ago

WGS

GeneDx price target lowered to $55 from $60 at TD Cowen

TD Cowen lowered the firm’s price target on GeneDx (WGS) to $55 from $60 and keeps a Buy...

3M ago

WGS

GeneDx price target lowered to $90 from $170 at BTIG, removed from Top Picks

BTIG lowered the firm’s price target on GeneDx (WGS) to $90 from $170 and keeps a Buy rating...

3M ago

WGS

GeneDx price target lowered to $70 from $100 at Guggenheim

Guggenheim lowered the firm’s price target on GeneDx (WGS) to $70 from $100 and keeps a Buy rating...

3M ago

WGS

WGS FAQ

What was Genedx Holdings Corp.’s price range in the past 12 months?

Genedx Holdings Corp. lowest stock price was $32.21 and its highest was $170.87 in the past 12 months.

What is Genedx Holdings Corp.’s market cap?

Genedx Holdings Corp.’s market cap is $1.88B.

When is Genedx Holdings Corp.’s upcoming earnings report date?

Genedx Holdings Corp.’s upcoming earnings report date is Aug 03, 2026 which is in 14 days.

How were Genedx Holdings Corp.’s earnings last quarter?

Genedx Holdings Corp. released its earnings results on May 04, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.015 by -$0.265.

Is Genedx Holdings Corp. overvalued?

According to Wall Street analysts Genedx Holdings Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Genedx Holdings Corp. pay dividends?

Genedx Holdings Corp. does not currently pay dividends.

What is Genedx Holdings Corp.’s EPS estimate?

Genedx Holdings Corp.’s EPS estimate is -0.19.

How many shares outstanding does Genedx Holdings Corp. have?

Genedx Holdings Corp. has 29,688,026 shares outstanding.

What happened to Genedx Holdings Corp.’s price movement after its last earnings report?

Genedx Holdings Corp. reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.015. Following the earnings report the stock price went down -49.198%.

Which hedge fund is a major shareholder of Genedx Holdings Corp.?

Currently, no hedge funds are holding shares in WGS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

GeneDx Holdings Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

13.41%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Genedx Holdings Corp.

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

GeneDx Holdings (WGS) Earnings & Revenues

Historic Earnings Reports

WGS Revenue Breakdown

96.59% Diagnostic test revenue

3.41% Other

WGS Stock 12 Month Forecast

Average Price Target

$80.29

▲(21.72% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","164":"$164","79.25":"$79.3","107.5":"$107.5","135.75":"$135.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$100.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80.28571428571429,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$80.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$63.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,79.25,107.5,135.75,164],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.71,73.88615384615385,76.06230769230768,78.23846153846154,80.41461538461539,82.59076923076923,84.76692307692308,86.94307692307692,89.11923076923077,91.29538461538462,93.47153846153846,95.64769230769231,97.82384615384615,{"y":100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.71,72.36967032967033,73.02934065934066,73.68901098901098,74.34868131868132,75.00835164835165,75.66802197802198,76.3276923076923,76.98736263736264,77.64703296703297,78.3067032967033,78.96637362637362,79.62604395604396,{"y":80.28571428571429,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.71,71.03999999999999,70.36999999999999,69.69999999999999,69.03,68.36,67.69,67.02,66.35,65.67999999999999,65.01,64.34,63.67,{"y":63,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":90.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.18,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.44,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.91,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.61,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.06,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.01,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.2,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.52,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.38,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.71,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >